Centenial Surgical Suture Ltd
₹ 81.9
-4.93%
14 Aug
- close price
About
Incorporated in 1995, Centenial Surgical Suture is engaged in the development, manufacturing and supply of Medical Devices.[1]
Key Points
- Market Cap ₹ 29.9 Cr.
- Current Price ₹ 81.9
- High / Low ₹ 189 / 73.0
- Stock P/E
- Book Value ₹ 78.3
- Dividend Yield 0.00 %
- ROCE 2.52 %
- ROE -7.42 %
- Face Value ₹ 10.0
Unsung hero
Parbati Giri
She joined the freedom movement at 11 and was imprisoned during the Quit India Movement at 16. She later devoted her life to orphans, women and rural communities.
Unsung hero
Manoranjan Sen Gupta
He was only 15 years old when he took part in swadeshi dacoities.
Pros
- Company has reduced debt.
- Stock is trading at 1.05 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.83% over past five years.
- Company has a low return on equity of -2.73% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.71 | 51.39 | 52.84 | 52.73 | 56.05 | 55.61 | 36.93 | 44.43 | 52.66 | 51.19 | 53.49 | 53.84 | 56.24 | |
| 46.47 | 46.71 | 47.95 | 48.26 | 50.64 | 49.68 | 31.82 | 39.94 | 48.26 | 46.04 | 47.07 | 48.75 | 50.21 | |
| Operating Profit | 5.24 | 4.68 | 4.89 | 4.47 | 5.41 | 5.93 | 5.11 | 4.49 | 4.40 | 5.15 | 6.42 | 5.09 | 6.03 |
| OPM % | 10.13% | 9.11% | 9.25% | 8.48% | 9.65% | 10.66% | 13.84% | 10.11% | 8.36% | 10.06% | 12.00% | 9.45% | 10.72% |
| 0.10 | 0.02 | 0.01 | 0.05 | 0.02 | 0.09 | 0.09 | 0.04 | 0.13 | 0.13 | 0.12 | 0.17 | 0.18 | |
| Interest | 1.61 | 1.65 | 1.77 | 1.51 | 1.89 | 2.31 | 2.12 | 1.93 | 1.77 | 2.62 | 3.90 | 3.34 | 3.31 |
| Depreciation | 0.83 | 0.68 | 0.59 | 0.60 | 0.69 | 1.55 | 1.55 | 1.53 | 1.30 | 1.39 | 4.25 | 4.00 | 3.97 |
| Profit before tax | 2.90 | 2.37 | 2.54 | 2.41 | 2.85 | 2.16 | 1.53 | 1.07 | 1.46 | 1.27 | -1.61 | -2.08 | -1.07 |
| Tax % | 34.14% | 34.18% | 32.68% | 36.10% | 29.12% | 39.81% | 37.25% | 42.06% | 39.73% | 11.02% | -9.32% | 6.25% | |
| 1.92 | 1.56 | 1.72 | 1.54 | 2.02 | 1.30 | 0.96 | 0.63 | 0.89 | 1.13 | -1.46 | -2.20 | -1.43 | |
| EPS in Rs | 5.26 | 4.28 | 4.71 | 4.22 | 5.54 | 3.56 | 2.63 | 1.73 | 2.44 | 3.10 | -4.00 | -6.03 | -3.92 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 8% |
| 3 Years: | 1% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 11% |
| 3 Years: | 1% |
| 1 Year: | -47% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | -3% |
| Last Year: | -7% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 |
| Reserves | 15.79 | 17.35 | 19.07 | 20.62 | 22.63 | 23.18 | 24.15 | 24.77 | 25.66 | 26.79 | 25.33 | 23.13 |
| 12.28 | 13.11 | 15.24 | 14.37 | 13.10 | 12.72 | 13.47 | 9.30 | 9.92 | 23.24 | 30.01 | 10.71 | |
| 21.80 | 16.68 | 16.07 | 14.89 | 15.61 | 27.96 | 27.00 | 21.85 | 25.40 | 23.70 | 23.83 | 40.53 | |
| Total Liabilities | 55.29 | 52.56 | 55.80 | 55.30 | 56.76 | 69.28 | 70.04 | 61.34 | 66.40 | 79.15 | 84.59 | 79.79 |
| 4.13 | 3.64 | 3.71 | 3.80 | 4.08 | 10.44 | 8.97 | 7.60 | 6.46 | 12.77 | 19.99 | 18.22 | |
| CWIP | 0.19 | 0.19 | 0.19 | 0.22 | 0.22 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 50.97 | 48.73 | 51.90 | 51.28 | 52.46 | 58.62 | 61.07 | 53.74 | 59.94 | 66.38 | 64.60 | 61.57 | |
| Total Assets | 55.29 | 52.56 | 55.80 | 55.30 | 56.76 | 69.28 | 70.04 | 61.34 | 66.40 | 79.15 | 84.59 | 79.79 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.21 | -1.51 | 0.00 | 1.76 | 1.55 | 2.08 | 1.97 | 4.75 | 1.30 | 6.21 | 17.07 | 7.28 | |
| -0.36 | -0.19 | -2.38 | -0.64 | -1.02 | -1.31 | -0.89 | -0.17 | -0.18 | -7.92 | -11.61 | -2.41 | |
| 0.96 | 0.82 | 2.14 | -0.88 | -1.27 | -0.37 | -1.27 | -4.87 | -1.05 | 2.06 | -5.93 | -4.89 | |
| Net Cash Flow | 0.80 | -0.88 | -0.25 | 0.24 | -0.75 | 0.40 | -0.18 | -0.28 | 0.07 | 0.35 | -0.47 | -0.02 |
| Free Cash Flow | -0.15 | -1.70 | -0.66 | 1.05 | 0.57 | 1.00 | 1.13 | 4.59 | 1.14 | -1.49 | 5.60 | 5.05 |
| CFO/OP | 23% | -15% | 0% | 59% | 44% | 50% | 50% | 112% | 42% | 129% | 270% | 144% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 138.21 | 132.75 | 130.76 | 125.29 | 134.80 | 153.26 | 221.39 | 160.44 | 142.71 | 134.05 | 125.56 | 123.93 |
| Inventory Days | 350.07 | 365.93 | 468.59 | 465.89 | 434.68 | 483.86 | 1,276.44 | 599.23 | 677.26 | 909.72 | 921.61 | 791.32 |
| Days Payable | 167.34 | 124.26 | 146.28 | 135.64 | 120.26 | 187.98 | 372.75 | 159.00 | 222.42 | 207.75 | 151.98 | 145.61 |
| Cash Conversion Cycle | 320.94 | 374.42 | 453.06 | 455.54 | 449.22 | 449.14 | 1,125.08 | 600.67 | 597.56 | 836.02 | 895.19 | 769.64 |
| Working Capital Days | 127.27 | 148.80 | 156.25 | 164.05 | 167.69 | 172.36 | 282.37 | 236.68 | 207.73 | 226.67 | 210.99 | 191.58 |
| ROCE % | 14.08% | 11.59% | 11.40% | 9.78% | 11.62% | 10.84% | 8.65% | 7.27% | 8.03% | 8.07% | 3.94% | 2.52% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Electricity Purchased Units kWh |
|
|||||||||
| Permanent Employees count |
||||||||||
| Export Revenue Share % |
||||||||||
| CABG Market Share in India % |
||||||||||
| Manufacturing Capacity Utilization % |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Intimation Of 31St Annual General Meeting (AGM) Of The Company, Cut-Off Date For Voting And E-Voting As Per Regulation 44 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]), Regulations, 2015.
- 31st AGM on September 28, 2026; e-voting from September 24-27, 2026, cutoff September 21.
-
Notice Of Book Closure As Per Regulation 42 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]), Regulations, 2015 For The Purpose Of 31St Annual General Meeting (E-AGM) To Be Held On September 28, 2026
- Book closure from September 22-28, 2026 for 31st e-AGM on September 28, 2026.
-
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
- Anuradha Kashikar resigned; Sapna Mhatre appointed CFO and KMP effective August 14, 2026.
-
Re-Appointment Of Whole Time Director Of The Company - Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('The SEBI Listing Regulation').
- Board approved reappointment of Anuradha Kashikar as Executive Director for three years from April 1, 2027, subject to AGM approval.
-
Intimation Of Appointment Of Internal Auditor - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.
- Centenial appointed Utsav Shah & Associates as internal auditor for FY 2026-27 on August 14, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
CSSL is engaged in the manufacturing of surgical sutures with a specialization
in absorbable and non-absorbable sutures (cardiovascular sutures and atraumatic needled sutures) that are primarily used in CABG surgeries and other medical devices. It has also started the manufacturing of surgical threads.